Healthcare - Biotechnology - NASDAQ - US
$ 2.66
-3.97 %
$ 220 M
Market Cap
-1.05
P/E
Price Target
Average
249.09%
Revenue Forecast
Estimate
11.60%
EBIT
Estimate
8.01%
Net Income
Estimate
11.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Editas Medicine, Inc.
Wall Street analysts predict an average 1-year price target for EDIT of $9.29 , with forecasts ranging from a low of $5 to a high of $15 .
EDIT Lowest Price Target
Wall Street Target
5 USD
87.97%
EDIT Average Price Target
Wall Street Target
9.29 USD
249.09%
EDIT Highest Price Target
Wall Street Target
15 USD
463.91%
REVENUE FORECAST
Revenue Forecast Chart EDIT
EBIT FORECAST
EBIT Forecast Chart EDIT
NET INCOME FORECAST
Net Income Chart EDIT